Microbot Medical Launches LIBERTY Robotic System in U.S. Market

Reuters11-05
Microbot Medical Launches LIBERTY Robotic System in U.S. Market

Microbot Medical Inc. has expanded its operations in the U.S. with the commencement of the limited market release of its LIBERTY® Endovascular Robotic System. The company has completed the necessary infrastructure to support the introduction, including hiring a core commercial team and establishing a logistics partnership. This limited release targets high procedure volume regions and aims to gather real-world insights ahead of a planned full market launch at the Society of Interventional Radiology conference in April 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9568906-en) on November 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment